# A Case of Autoimmune Polyglandular Syndrome Type 2 in Childhood: Unraveling a Rare and Complex Endocrine Puzzle

**Authors:** Felicita M Tayong, Faiza Gul, Kasagani Srujana, Phillip George, Aysha Habib, Nadia Khan, Nida Gul, Ayaz Ali

PMC · DOI: 10.7759/cureus.87595 · Cureus · 2025-07-09

## TL;DR

A rare case of APS-2 in a child with T1DM and hypothyroidism highlights the need for early diagnosis and endocrine evaluation in pediatric autoimmune conditions.

## Contribution

This paper presents a rare pediatric case of APS-2, emphasizing its atypical presentation and diagnostic importance in children.

## Key findings

- A nine-year-old boy with T1DM was diagnosed with APS-2 due to severe hypothyroidism and other clinical features.
- The case underscores the importance of comprehensive endocrine evaluation in pediatric autoimmune disorders.
- Management included levothyroxine replacement and close glycemic monitoring to improve outcomes.

## Abstract

Autoimmune polyendocrine syndrome type 2 (APS-2) is a rare autoimmune disorder characterized by the coexistence of multiple endocrine gland dysfunctions, most commonly type 1 diabetes mellitus (T1DM), autoimmune thyroid disease, and Addison’s disease. It typically manifests in middle-aged women, with pediatric cases being exceedingly uncommon. We present the case of a nine-year-old boy with a known history of T1DM diagnosed at the age of six years, who presented to the emergency department with severe hypoglycemia and was subsequently found to have severe hypothyroidism. Clinical features included growth retardation, coarse facial features, alopecia, developmental delay, and hepatomegaly. Laboratory investigations confirmed severe hypothyroidism alongside his known T1DM, fulfilling the diagnostic criteria for APS-2. The patient was managed with levothyroxine replacement and close glycemic monitoring. This case highlights the importance of considering APS-2 in pediatric patients with multiple autoimmune conditions, emphasizing the need for early recognition and comprehensive endocrine evaluation to guide appropriate management and improve long-term outcomes.

## Linked entities

- **Diseases:** type 1 diabetes mellitus (MONDO:0005147), autoimmune thyroid disease (MONDO:0005623), Addison’s disease (MONDO:0100480), hypothyroidism (MONDO:0005420), APS-2 (MONDO:0010012)

## Full-text entities

- **Diseases:** endocrine gland dysfunctions (MESH:D004701), developmental delay (MESH:D002658), autoimmune thyroid disease (MESH:D013967), autoimmune conditions (MESH:D001327), growth retardation (MESH:D006130), alopecia (MESH:D000505), T1DM (MESH:D003922), hepatomegaly (MESH:D006529), hypothyroidism (MESH:D007037), APS-2 (MESH:D016884), Addison's disease (MESH:D000224), hypoglycemia (MESH:D007003)
- **Chemicals:** levothyroxine (MESH:D013974)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12333465/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12333465/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12333465/full.md

---
Source: https://tomesphere.com/paper/PMC12333465